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Abstract Treatment of CHO.T cells with either PMA or 
insulin led to the activation of MAP kinase by ,~ 3-fold, and 
p90 rsk by ~ 4-fold. Over-expression of the a, 13i or y isoforms of 
protein kinase C caused a substantial enhancement of the effect 
of PMA on the activation of MAP kinase and p90 "~k, however, 
the effect of insulin was unchanged. Over-expression of the E 
isoform of protein kinase C did not alter the effect of either PMA 
or insulin on the activation of MAP kinase and p91Y sk. The 
results suggest hat protein kinase C isotypes ¢x, 13i and y, but not 
E, can mediate MAP kinase activation by PMA, and strongly 
support the hypothesis that protein kinase C isoforms can initiate 
distinct signalling pathways. 
Key words: MAP kinase; Phorbol ester; Insulin; 
Protein kinase C 
1. Introduction 
The mitogen-activated protein (MAP) kinases are central to 
the effects of a number of extracellular stimuli on cell growth 
and development [1,2]. These enzymes (which include the 
Erkl and Erk2 isoforms) are stimulated by growth factors, 
neurotrophins and insulin (reviewed in [1,2]) and it has been 
known for some time that they are also activated by phorbol 
esters [3]. The pathway by which Erkl and Erk2 are activated 
by growth factors is relatively well characterized. Erkl and 
Erk2 are phosphorylated and activated by the dual-specificity 
MAP kinase kinase, which is in turn activated through phos- 
phorylation by Raf-1 (reviewed in [4,5]). Raf-1 appears to be 
activated by a rather complex mechanism which involves, in 
part, its association with the GTP-bound form of Ras [6,7] as 
well as other proteins uch as 14-3-3 [8,9] and v-Src [10]. It has 
also been suggested that protein kinase C can phosphorylate 
and activate Raf-1 [11]. 
Protein kinase C comprises a group of related serine/threo- 
nine-specific protein kinases of which there are at least ten 
distinct members. These isozymes can be classified into con- 
ventional (e.g., ct, [3 and y), novel (e.g., 8 and e) and atypical 
(e.g., ~) isoforms. The conventional nd novel isoforms, but 
not the ~ isoform, bind phorbol esters (reviewed in [12]). 
The fact that multiple isoforms of protein kinase C exist, 
and that they exhibit distinct tissue distribution profiles and 
*Corresponding author. Fax: (44) (117) 928 8274. 
E-mail: tavare@bsa.bristol.ac.uk 
Abbreviations: MAP kinase, mitogen-activated protein kinase; Erk, 
extracellular signal-regulated protein kinase; PMA, phorbol 12- 
myristate 13-acetate; PKC, protein kinase C; MBP, myelin basic 
protein. 
are activated by different external stimuli (reviewed in [13]), 
suggests their functional divergence. For example, distinct iso- 
forms may phosphorylate different substrates and thus acti- 
vate distinct cellular signalling pathways. A limited number of 
studies have provided evidence that this may be the case. For 
example, Goode et al. [14] found that glycogen synthase ki- 
nase-3[3 was a good substrate in vitro for the cx, 1St and % but 
not e, isoforms of protein kinase C. Hata et al. [15] found that 
the ~x, 13n and e isoforms could mediate transcriptional ctiva- 
tion of promoters possessing either a TPA-response lement 
(TRE) or a serum-response element (SRE). On the other 
hand, the Y isoform mediated activation of the SRE, but not 
TRE-dependent transcription. Spence t al. [16] found that the 
tx and e isoforms of PKC, but not [31 or y, exhibited an in- 
duction of expression of phosphodiesterase activity, largely 
through a transcription-dependent mechanism. The data sug- 
gest that the protein kinase C isoforms subserve distinct in- 
tracellular signalling roles. In the current study this possibility 
was tested by measuring the ability of the tx, ~I, Y and e iso- 
forms of protein kinase C to activate mitogen-activated pro- 
tein kinase. 
2. Materials and methods 
2.1. Materials 
All reagents were as previously described [17] except issue culture 
media and serum which were from Gibco BRL (Paisley, UK). An 
antiserum (pan-Erkl/2) reactive towards both Erkl and Erk2 was 
raised towards the C-terminal 15 amino acids of Erkl and has been 
previously described [18]. CHO.T cells and CHO.T cells overexpres- 
sing the ~x, 13i, ~' or E isoforms of protein kinase C have been pre- 
viously described [18] and were maintained in Ham's F12 medium 
supplemented with 5% foetal calf serum and 200 gg/ml G418. 
2.2. MAP kinase and p90 rsk assays 
Approx. 2× 106 cells in 60 mm dishes were serum starved by in- 
cubation at 37°C for 16 h in Ham's F12 medium containing 1% FCS 
and then for 2 h in serum free Ham's F12. After incubation with 
ligands for the times and at the concentrations i dicated in the figure 
legends, the cells were washed with 2 ml of ice-cold phosphate buf- 
fered saline and extracted rapidly by scraping into 0.5 ml of ice-cold 
extraction buffer (50 mM ~-glycerophosphate (pH 7.4)/1.5 mM 
EGTA/1 mM benzamidine/1 mM dithiothreitol/0.5 mM NasVO4/0.1 
mM PMSF/1 gM microcystin/1 gg/ml each of pepstatin, antipain and 
leupeptin). MAP kinases were assayed either in the crude cell lysate 
[19] or after immunopurification with a pan-Erk antiserum that is 
specific for Erkl and Erk2 as described [17], using 0.5 mg/ml-myelin 
basic protein as substrate, p90r~k was assayed in the crude cell lysates 
using the peptide RRLSSLRA as substrate [19]. 
2.3. Two-dimensional phosphopeptide mapping of the human insulin 
receptor 
Cells were pre-equilibrated with 1 mCi of S2pi in 2 ml phosphate- 
free and serum-free DMEM for 3 h and then incubated in the absence 
or presence of 1.6 gM PMA for 30 min at 37°C. Cells were extracted 
and the insulin receptor isolated, digested with trypsin and the resul- 
tant phosphopeptides were separated by two-dimensional thin-layer 
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chromatography as previously described [20]. The thin-layer plate was 
subjected to autoradiography for 7 days. 
3. Results and discussion 
CHO.T cells express approx. 106 human insulin receptors 
per cell and have also been shown to express low levels of 
endogenous PKCa, PKC7 and PKC~ [18]. We have pre- 
viously reported the generation of CHO.T cell lines that stably 
over-express PKCc~, PKC~, PKC 7 or PKCe [18]. We utilised 
these cell types to examine the ability of the various protein 
kinase C isotypes to activate MAP kinase. 
CHO.T cells (controls) or CHO.T cells over-expressing the 
various PKC isotypes were incubated in the absence or pres- 
ence of insulin or phorbol ester. As shown in Fig. la both 
insulin and phorbol ester stimulated the activity of MAP ki- 
nase in control CHO.T cells by ,~ 3-fold. Upon over-expres- 
sion of any of the protein kinase C isotypes the effect of 
insulin remained about the same as that observed in control 
CHO.T cells (Fig. la). However, the effect of phorbol ester 
was enhanced approx. 5-fold upon over-expression f PKC~ 
and PKCI3b and by approx. 2-fold in cells over-expressing 
PKC 7. The effect of phorbol ester was unchanged in cells 
over-expressing PKCe (Fig. la). Similar data were obtained 
by assaying MAP kinase in immunoprecipitates using anti- 
MAP kinase specific antisera (Fig. lb), where over-expression 
of PKCot and PKC~I caused a marked enhancement of the 
ability of phorbol esters to activate MAP kinase. This was 
also observed, but to a lesser extent, in cells over-expressing 
PKC 7. Again, cells over-expressing PKCe showed no differ- 
ence from the control CHO.T cells (Fig. lb). 
The results strongly suggest hat the t~, [~t and 7, but not e, 
isotypes of protein kinase C can mediate the activation of 
MAP kinase by PMA in these cells. Furthermore, they also 
suggest hat protein kinase C does not mediate the ability of 
insulin to activate MAP kinase. Consistent with the latter 
proposal, insulin still promoted a quite normal activation of 
MAP kinase in cells in which the phorbol ester-sensitive PKC 
isotypes were down-regulated by long-term treatment with 
PMA (M.D., unpublished observations). One of the target 
substrates for MAP kinase is the serine/threonine kinase 
p90 'sk [21]. Phosphorylation of the enzyme by MAP kinase 
is accompanied by its activation. The activity of p90 'sk should, 
therefore, reflect changes in the activity of its upstream reg- 
ulator, MAP kinase. We thus examined the activation of this 
enzyme in cells over-expressing the various PKC isoforms 
using a specific substrate for p90 'sk based on the sites phos- 
phorylated in the ribosomal subunit $6; we have previously 
shown this to be a specific assay for the activity of this enzyme 
in crude cell lysates [19]. As shown in Fig. 2, both PMA and 
insulin had approx. 4-fold effects on the activation of p90 'sk. 
Over-expression of PKCc~, PKC[3t and PKC 7 all led to 
approx. 3-fold enhancement of the effect of phorbol ester on 
p90 r~k activation. By contrast, and consistent with what is 
observed with MAP kinase in Fig. 1, over-expression of 
PKCe did not change the response of p90 r~k to phorbol ester 
stimulation. The effect of insulin on p90 rsk activation was un- 
changed upon over-expression f any of the PKC isoforms 
(Fig. 2). 
It is interesting that the enhanced activation of p90 rsk upon 
over-expression f PKC7 reaches the same level as that ob- 
served when over-expressing PKC~ or ~[ (Fig. 2). This con- 
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Fig. 1. Activation of MAP kinase by phorbol esters and insulin. 
CHO.T cells (control) or cells over-expressing the various PKC iso- 
forms (as indicated) were serum starved and incubated without (C) 
or with either 100 nM insulin for 5 min (I) or 1.6 gM PMA for 30 
min (P). The cells were extracted and MAP kinase activity assayed 
in the crude cell lysates (a) or after specific immunoprecipitation 
with anti-MAP kinase antibodies (b) as described in section 2. The 
data shows the results pooled from four (a) or three (b) independent 
experiments (means + S.E.M.). 
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Fig. 2. Activation of p90 rsk by phorbol esters and insulin. CHO.T 
cells (control) or cells over-expressing the various PKC isoforms (as 
indicated) were incubated as described for Fig. 1. The cells were ex- 
tracted and p90 rsk activity assayed in the crude cell lysate as de- 
scribed in section 2. The data shows the results pooled from four 
independent experiments (mean + S.E.M.). 
trasts with the ability of PKCy over-expression to induce a 
lower enhancement of MAP kinase activity when compared to 
that induced by PKCct and [3i over-expression (Fig. 1). This 
suggests a degree of signal amplification between MAP kinase 
and p90 r~k, such that only a submaximal level of MAP kinase 
activation is required to produce maximal activation of p90 r'k. 
We next wanted to confirm that PKCe was active in the 
CHO.T-PKCe cell line. We have previously demonstrated that 
over-expression f PKCtx enhances the effect of phorbol esters 
on the phosphorylation of the human insulin receptor on 
serine and threonine residues [18]. We thus performed tryptic 
phosphopeptide mapping experiments on insulin receptors 
isolated from CHO.T cells over-expressing PKC~I or PKCe 
which were metabolically labelled with 32P i. The maps ob- 
tained were compared with peptide maps derived from insulin 
receptors isolated from similarly treated parental CHO.T 
cells. In CHO.T cells, PMA promoted an increase in the phos- 
phorylation of an insulin receptor phosphothreonine-contain- 
ing peptide (peptide 'T'). In the experiment shown in Fig. 3, 
and using scanning densitometry, this increase in T-peptide 
phosphorylation was shown to be 1.9-fold. We have pre- 
viously shown this peptide to correspond to Thr-1348 [22]. 
In CHO.T cells over-expressing PKCe, the effect of PMA 
was enhanced to 4.5-fold (Fig. 3). A quantitatively similar 
enhancement in Thr-1348 phosphorylation was observed in 
cells over-expressing PKC~I (4.3-fold; Fig. 3) or PKCy (see 
[18]). In two additional independent experiments, the effect of 
PMA on Thr-1348 phosphorylation i  CHO.T and CHO.T- 
PKCe cells was 1.9-versus 3.0-fold, and 0.45-versus 2.2-fold, 
respectively. This demonstrates that PKCe is not only active 
in these cells, but confirms that it can mediate nhanced phos- 
phorylation of insulin receptor Thr-1348, but not enhanced 
MAP kinase activation by PMA. 
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Secondly, in the same clone of CHO.T cells as used in our 
studies, Spence et al. [16] have shown that over-expression f 
PKCe enhances the basal expression of the PDE1 isoform of 
phosphodiesterase when compared to the parental CHO.T cell 
line. 
The data, therefore, strongly suggest hat at least in CHO 
cells PKCtx, PKC[~I and PKCT, but not PKCe, can mediate 
phorbol ester-stimulation f MAP kinase activity. The results 
are consistent with studies by Yamaguchi et al. [23] who 
found that PKC~ and PKC8 enhanced the ability of phorbol 
esters to activate MAP kinase. The point at which the PKCct, 
~I, 8 and ~' isoforms feed into the MAP kinase pathway has 
not been addressed, nor has the molecular basis for the in- 
ability of PKCe to couple to this pathway. However, it may 
be due to Raf-1 being an efficient substrate for PKCct, PKC~b 
PKC8 and PKC~/, but not for PKCe. This intriguing possibi- 
lity requires further testing. It would also be consistent with 
the fact that PKCe exhibits a quite distinct substrate specifi- 
city in vitro to PKCct, PKCD and PKCy [14,24]. 
Interestingly, in CHO cells the subset of isoforms of protein 
kinase C that lead to MAP kinase activation (i.e., et, ~li and T, 
but not e) differs from that leading to elevated basal expres- 
sion of the phosphodiesterase PD1 (i.e., PKCct and e, but not 
[3i or 7; [16]). These observations greatly increase the apparent 
complexity of signalling initiated by protein kinase C iso- 
forms, and suggests that even within a subgroup (i.e., conven- 
tional isoforms) there is a further level of signalling specificity. 
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